Immupharma Share News (IMM)

13 Aug 2013

ImmuPharma, a drug developer, has reported that its lead cancer programme, IPP-204106, is progressing, and that trials are being conducted at three ho...

28 Jan 2013

Dr Ajay Agrawal, Non-Executive Director of ImmuPharma, sold a stack of shares in the AIM-listed drug company, it was announced Monday. Agrawal traded...

28 Jan 2013

Drug development firm ImmuPharma said Monday that its key scientific collaboration partner and the inventor of ImmuPharma's lead compound, Lupuzor, ha...

27 Mar 2012

Drug development firm ImmuPharma increased its losses during 2011 but managed to regain the rights to its most important compound. The loss for the y...

24 Jan 2012

The Managing Director of SABMiller's African division bought a round of shares just one day before the drinks giant announced it has signed a definiti...

5 Apr 2011

Drug discovery group Immupharma fell into losses in the year to 31 December, but pointed to progress with its ongoing trials. Pre-tax losses totalled...

23 Jun 2010

Dow Jones smallcap news is on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps MARIANA...

23 Jun 2010

LONDON (Dow Jones)--Immupharma PLC (IMM.LN), a specialist drug discovery and development company, said Wednesday that Cephalon Inc. (CEPH), its licens...